Moody Aldrich Partners LLC raised its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 4.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 273,512 shares of the biopharmaceutical company’s stock after buying an additional 11,075 shares during the quarter. Moody […]